newsfilter
← Latest News
GlobeNewswire·

Rein Therapeutics Expands Phase 2 RENEW Trial into United Kingdom

16 patients enrolled to date in trial of LTI-03 in idiopathic pulmonary fibrosis (IPF)First patient randomized in the United KingdomClinical trial sites now actively enrolling in the United States, Australia, and the